RoB2 (revised version 2019), an authoritative tool for assessing the risk of bias in randomized controlled trials, has been updated and improved based on the original version. This article elaborated and interpreted the background and main content of RoB2 (revised version 2019), as well as the operation process of the new software. Compared with the previous version of RoB2 (revised version 2018), RoB2 (revised version 2019) has the advantages of rich content, complete details, accurate questions, and simple operation, etc. Additionally, it is more user-friendly for researchers and beginners. The risk bias assessment of randomized controlled trials is more comprehensive and accurate, and it is an authoritative, trustworthy, and popular tool for evaluating the risk of bias in randomized controlled studies in medical practice.
Citation： LIU Jinchi, LIU Chang, HUA Chengge. Risk bias assessment tool RoB2 (revised version 2019) for randomized controlled trial : an interpretation. Chinese Journal of Evidence-Based Medicine, 2021, 21(6): 737-744. doi: 10.7507/1672-2531.202011144 Copy